28 September 2021
PRESS RELEASE
We are particularly pleased to announce that, today, BioMAdvanced Diagnostics is entering a new stage in its development and is setting up part of its staff in an office of the Faculty of Medicine made available to it by the University of Nantes. The company will also have access to the equipment of the CRTI laboratory located in the premises of the Nantes University Hospital to accelerate product development.
The head office of the company remains located at 6, rue Edouard Nignon in Nantes.
As a reminder, BioMAdvanced Diagnostics, a BioTech/MedTech start-up from Nantes, a spinoff from the CRTI laboratory (Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM – University of Nantes) and from the University Hospital (CHU) of Nantes, which aims to offer companion molecular diagnostic tests and biomarkers in connection with the immune response of patients. On the basis of a common technological base, the first applications will concern: 1) improving the follow-up of patients who have received a kidney or lung transplant, and 2) determining the best drug to administer to patients with ulcerative colitis (UC). These tests are designed to be integrated into standard diagnostic and treatment protocols, easy to use by staff caring for targeted patients. Predictive scores are produced using algorithms based on the combination of signatures from the expression of selected genes and clinical parameters.